Palbociclib 125mg
Palbociclib-125
Composition: Palbociclib – 125
Therapeutic Class: Anti-neoplastic
Palbocib: Globally Validated for Efficacy and Safety
Palbocib is widely prescribed by oncologists and is available worldwide.
Aprazer Healthcare: A Global Pharmaceutical Name
Aprazer, a leading pharmaceutical company manufacturing a range of life-saving medicines in varied therapeutic segments. As the largest oncology medicine exporter, it exports anticancer medicines to 50+ countries. WHO-GMP certified, assured therapeutic efficacy and safety.
What is Palbocib?
It is a targeted therapy drug that is used for:
- • Hormone-positive (HR+) breast cancer
- • HER2-negative and advanced-stage breast cancer
- • It targets genetic mutations of the enzymes like HER2, CDK
Uses of Palbocib
- • HR+ cancer – hormone receptor-positive breast cancer
- • HER2-negative breast cancer
- • Metastatic Breast Cancer
How does it work?
Tyrosine Kinase Inhibitor It inhibits the crucial enzymes and arrests the stage of the cell cycle, inhibiting cell proliferation.
- • Stops multiplication
- • Stops tumor growth
Common Side Effects
- • Low blood count – low neutrophils, low RBC count
- • Loss of appetite
- • Nausea, vomiting
- • Mouth ulcers
- • Tiredness
- • Skin rashes
- • Hair loss
Serious Side Effects
- • Severe fall in Neutrophils
- • Fatal lung inflammation – Pneumonitis
- • QT prolongation
- • Elevated liver enzymes
- • Opportunistic infections – fungal, bacterial
Precautions
To be used cautiously in patients with:
- • Pre-existing lung disease
- • Liver dysfunctions
- • Renal dysfunctions
- • Blood disorders
- • Cardiac abnormalities
Contraindication
- • Not to be used if any previous allergy or hypersensitivity to Palbociclib or any excipients
- • Breastfeeding mothers
- • Pregnant women
Warning
To be used under medical prescription only.
Important Safety and Monitoring Information
Regular monitoring of the:
- • Liver function – Elevated liver enzymes
- • Blood count – CBC count
- • Respiratory functions – interstitial lung disease
- • Cardiac functions – QT prolongation
- • Opportunistic infections – fungal, bacterial
Formulations based on "Palbociclib 125mg" (11)
Kixta 125mg Capsule
Palbociclib (125mg)
Kixta 125mg Capsule is used to treat patients with metastatic breast cancer (oestrogen receptor-positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem with h...
Bdpalbo 125mg Capsule
Palbociclib (125mg)
Bdpalbo 125mg Capsule is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem with...
Primcyv 125mg Capsule
Palbociclib (125mg)
Primcyv 125mg Capsule is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem with...
Piclib Capsule
Palbociclib (125mg)
Piclib Capsule is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem with hormon...
Paleno 125mg Capsule
Palbociclib (125mg)
Paleno 125mg Capsule is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem with ...
Palborest 125mg
Palbociclib (125mg)
Palborest 125mg Tablet is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem wit...
Palbomed 125mg
Palbociclib (125mg)
Palbomed 125mg Capsule is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem wit...
Palbocib-125
Palbociclib (125mg)
Palbocib-125 is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem with hormonal...
Palbinas 125mg
Palbociclib (125mg)
Palbinas 125mg Capsule is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem wit...
Palbace 125mg
Palbociclib (125mg)
Palbace 125mg Capsule is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem with...
Pabreca 125mg
Palbociclib (125mg)
Pabreca 125mg Capsule is used to treat patients with metastatic breast cancer (oestrogen receptor positive, human epidermal growth factor receptor 2-negative). This treatment is used in tandem with...